December 16th. 2021. Palobiofarma announces that it has been included among the 99 innovative companies in the European Innovation Council Accelerator.
Palobiofarma has received the approval of the European project that finances Phase II of the PBF-680 product in COPD. Additionally, it offers the possibility of partial financing of Phase III of PBF-680....